Reduced stem cell mobilization in mice receiving antibiotic modulation of the intestinal flora: Involvement of endotoxins as cofactors in mobilization

Blood

Volumn 103, Issue 1, 2004, Pages 340-346

  Velders, Gerjo A ^b   Van Os, Ronald ^b   Hagoort, Henny ^b   Verzaal, Perry ^b   Guiot, Henri F L ^b   Lindley, Ivan J D ^b   Willemze, Roel ^b   Opdenakker, Ghislain ^b   Fibbe, Willem E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; CYTOKINE; ENDOTOXIN; FLT3 LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 8; METRONIDAZOLE; POLYMYXIN B;

AEROBIC BACTERIUM; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; IMMUNOMODULATION; INTESTINE FLORA; MALE; NONHUMAN; PRIORITY JOURNAL; STEM CELL MOBILIZATION; WILD TYPE;

EID: 0347597743     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-07-2270     Document Type: Article

References (53)

1. Preisler HD, Goldstein IM, Henderson ES. Gastrointestinal "sterilization" in the treatment of patients with acute leukemia. Cancer. 1970;26:1076-1081.
2. Verhoef J, Rozenberg-Arska M, Dekker AW. Prevention of bacterial and fungal infections in granulocytopenic patients. Eur J Cancer Clin Oncol. 1989;25:1345-1350.
3. Levine AS, Siegel SE, Schreiber AD, et al. Protected environment and prophylactic antibiotics: a prospective controlled study of their utility in the therapy of acute leukemia. N Engl J Med. 1973;288:477-483.
4. Rodriguez V, Bodey GP, Freireich EJ, et al. Randomized trial of protected environment: prophylactic antibiotics in 145 adults with acute leukemia. Medicine (Baltimore). 1978;57:253-266,
5. Van der Waaij D, Berghuis-de Vries JM. Selective elimination of Enterobacteriaceae species from the digestive tract in mice and monkeys. J Hyg (Lond). 1974;72:205-211.
6. Wade JC, Schimpff S, Hergadon MT, et al. A comparison of trimetoprim sulfamethoxazole plus nystatin with gentamycin plus nystatin in the prevention of infections in acute leukemia. N Engl J Med. 1981;304:1057-1062.
7. Winston DJ, Ho WG, Nakao SL, Gale RP, Champlin RE. Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients. Am J Med. 1986;80:884-890.
8. Badhuri S, Kurrle E, Krieger D, et al. H. Infection prophylaxis in acute leukemia patients: comparison of selective and total decontamination of gastrointestinal tract. Folia Haematol (Leipzig). 1982;109:377-389.
9. Bow EJ, Rayner E, Scott BA, Louie ThJ. Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection profylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration. Antimicrob Agents Chemother. 1987;31:551-557.
10. Guiot HFL, Van Furth R. Partial antibiotic decontamination. Br J Med. 1977;1:800-802.
11. De Jongh CA, Joshi JH, Newman KA. Antibiotic synergism and response in gram negative bacteremia in granulocytopenic cancer patients. Am J Med. 1986;80:96-100.
12. Rozenberg-Arska M, Dekker AW, Verhoef J. Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on the fecal flora. J Infect Dis. 1985;152:104-107.
13. Dekker AW, Rozenberg-Arska M, Verhoef J. Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. Ann Intern Med. 1987;106:7-11.
14. Shpall EJ. The utilization of cytokines in stem cell mobilization strategies. Bone Marrow Transplant. 1999;23:13-19.
15. Kennedy MJ. Peripheral blood progenitor cell mobilization: a clinical review. Pharmacotherapy. 1998;18:3-8.
16. Demirer T, Besinger WI, Buckner CD. Peripheral blood stem cell mobilization for high dose chemotherapy. J Hematother. 1999;8:103-113.
17. Gratwohl A, Baldomero H, Hermans J. Hematopoietic precursor cell transplants in Europe: activity in 1994: report from the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 1996;17:137-148.
18. Russell NH, Gratwohl A, Schmitz N. Developments in allogeneic peripheral blood progenitor cell transplantation. Br J Haematol. 1998;103:594-600.
19. Lieschke GJ, Burgess AW. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med. 1992;327:99-106.
20. Bensinger WI, Price TH, Dale DC, et al. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood. 1993;8:1883-1888.
21. Gianni AM, Siena S, Bregni M, et al. Granulocyte-macrophage colony-stimulating factor to harvest circulating hematopoietic stem cells for autotransplantation. Lancet. 1989;2:580-584.
22. Tong J, Gordon MS, Srour EF, et al. In vivo administration of recombinant methionyl human stem cell factor expands the number of human marrow hematopoietic stem cells. Blood. 1993;82:784-791.
23. Brasel K, McKenna HJ, Morrissey PJ, et al. Hematologic effects of fit 3 ligand in vivo in mice. Blood. 1996;88:2004-2012.
24. Fibbe WE, Hamilton MS, Laterveer LL, et al. Sustained engraftment of mice transplanted with IL-1 primed blood derived stem cells. J Immunol. 1992;148:417-421.
25. Ganser A, Lindemann A, Seipelt G, et al. Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure. Blood. 1990;76:666-676.
26. Laterveer LL, Lindley IJD, Heemskerk DPM, et al. Rapid mobilization of hematopoietic progenitor cells in rhesus monkeys by a single intravenous injection of interieukin-8. Blood. 1996;87:781-788.
27. Torii Y, Nitta Y, Tawara T, et al. Mobilization of primitive hematopoietic progenitor cells and stem cells with long-term repopulating ability into peripheral blood in mice by pegylated recombinant human megakaryocyte growth and development factor. Br J Haematol. 1998;103:1172-1180.
28. Molineux G, McCrea C, Yan XQ, Kerzic P, McNiece I. Fit-3 ligand synergizes with granulocyte colony-stimulating factor to increase neutrophil numbers and to mobilize peripheral blood stem cells with long-term repopulating potential. Blood. 1997;89:3998-4004.
29. Schmitz N, Dreger P, Suttorp M, et al. Primary transplantation of allogenic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood. 1995;85:1666-1672.
30. Bensinger W, Weaver FR, Appelbaum FR, et al. Transplantation of allogenic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood. 1995;85:1655-1658.
31. To LB, Haylock DN, Simmons PJ, Juttner CA. The biology and clinical uses of blood stem cells. Blood. 1997;89:2233-2258.
32. Cline MJ, Golde DW. Mobilization of hematopoietic stem cells (CFU-C) into the peripheral blood of man by endotoxin. Exp Hematol. 1977;5:186-190.
33. Vos O, Wiischut IJ. Further studies on mobilization of CFUs. Cell Tissue Kinet. 1979;12:256-267.
34. Vos O, Buurman WA, Ploemacher RE. Mobilization of haematopoietic stem cells (CFU) into the peripheral blood of the mouse; effects of endotoxin and other compounds. Cell Tissue Kinet. 1972;5:467-479.
35. Wise R, Andrews JM, Edwards LJ. In vitro activity of Bay 09867, a new quinole derivate, compared with those of other antimicrobial agents. Antimicrob Agents Chemother. 1983;23:559-564.
36. Emmelot CH, Van der Waaij D. The dose at which neomycin and polymyxin B can be applied for selective decontamination of the digestive tract in mice. J Hyg (Lond). 1980;84:331-340.
37. Polymyxins. In: Kucers A, Crowe SM, Grayson ML, Hoy JF, eds. The Use of Antibiotics. Oxford, United Kingdom: Butterworth-Heinemann; 1997:667-675.
38. Kellogg TA, Lazaron V, Wasiluk KR, Dunn DL. Binding specificity of polymyxin B, BPI, LALF, and anti-deep core/lipid a monoclonal antibody to lipopolysaccharide partial structures. Shock. 2001;15:124-129.
39. Gorris H, De Boer F, Van der Waaij D. Oral administration of antibiotics and intestinal flora associated endotoxin in mice. Scand J Infect Dis. 1986;18:55-63.
40. Lee AJ, Gordon J, Lee C-J, Dubos R. The mouse intestinal microflora with emphasis on the strict anaerobes. J Exp Med. 1970;133:339-352.
41. Dubreuil L, Devos J, Neut C, Romond C. Susceptibility of anaerobic bacteria from several French hospitals to three major antibiotics. Antimicrob Agents Chemother. 1984;25:764-766.
42. Lindley IDJ, Aschauer H, Seifert JM, et al. Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil activating factor: biological equivalence between natural and recombinant neutrophil-activating factor. Proc Natl Acad Sci U S A. 1988;85:9199-9203.
43. Velders GA, Pruijt JFM, Van Os RP, et al. Enhancement of G-CSF-induced mobilization by antibodies to the β2-integrins LFA-1 and Mac-1. Blood. 2002;100:327-333.
44. Ploemacher R. Cobblestone area forming cell (CAFC) assay. In: Freshney RI, Pragnell IB, Freshney MG, eds, Culture of Hematopoietic Cells. New York, NY: Wiley-Liss; 1994:1-21.
45. Van Os R, Dawes D, Mislow J, Witsell A, Mauch P. Host conditioning with 5-fluorouracil and kit-ligand to provide for long-term bone marrow engraftment. Blood. 1997;89:2376-2383.
46. Fazekas de St Groth S. The evaluation of limiting dilution assays. J Immunol Methods. 1982;49: R11-R23.
47. Masure S, Billiau A, Van Damme J, Opdenakker G. Human hepatoma cells produce an 85-kDa gelatinase regulated by phorbol 12-mysirate 13-acetate. Biochim Biophys Acta. 1990;1052:317-325.
48. Meyrick BO, Ryan VA, Brigham KL. Direct effect of E coli endotoxin on structure and permeability of pulmonary endothelial non-layers and the endothelial layer of intestinal explants. Am J Pathol. 1986;122:140-155.
49. Schletter J, Heine H, Ulmer AJ, Rietschel ET. Molecular mechanisms of endotoxin activity. Arch Microbiol. 1995;164:383-389.
50. Pruijt JFM, Verzaal P, Van Os R, et al. Neutrophils are indispensable for hematopoietic stem cell mobilization by interleukin-8 in mice. Proc Natl Acad Sci U S A. 2002;99:6228-6233.
51. Levesque JP, Takamatsu Y, Nilsson SK, Haylock DN, Simmons PJ. Mobilization of hematopoietic progenitor cells into peripheral blood is associated with VCAM-1 proteolytic cleavage in the bone marrow. Blood. 2001;98;1289-1297.
52. Pruijt JFM, Fibbe WE, Laterveer L, et al. Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against gelatinase B (MMP-9). Proc Natl Acad Sci U S A. 1999;96:10863-10868.
53. Fan J, Malik AB. Toll-like receptor-4 (TLR4) signaling augments chemokine-induced neutrophil migration by modulating cell surface expression of chemokine receptors. Nat Med. 2003;4:315-321.